Literature DB >> 16958079

Health expenditure growth: reassessing the threat of ageing.

Brigitte Dormont1, Michel Grignon, Hélène Huber.   

Abstract

In this paper we evaluate the respective effects of demographic change, changes in morbidity and changes in practices on growth in health care expenditures. We use microdata, i.e. representative samples of 3441 and 5003 French individuals observed in 1992 and 2000. Our data provide detailed information about morbidity and allow us to observe three components of expenditures: ambulatory care, pharmaceutical and hospital expenditures. We propose an original microsimulation method to identify the components of the drift observed between 1992 and 2000 in the health expenditure age profile. On the one hand, we find empirical evidence of health improvement at a given age: changes in morbidity induce a downward drift of the profile. On the other hand, the drift due to changes in practices is upward and sizeable. Detailed analysis attributes most of this drift to technological innovation. After applying our results at the macroeconomic level, we find that the rise in health care expenditures due to ageing is relatively small. The impact of changes in practices is 3.8 times larger. Furthermore, changes in morbidity induce savings which more than offset the increase in spending due to population ageing. Copyright 2006 John Wiley & Sons, Ltd.

Mesh:

Year:  2006        PMID: 16958079     DOI: 10.1002/hec.1165

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  23 in total

Review 1.  The effect of population aging on health expenditure growth: a critical review.

Authors:  Claudine de Meijer; Bram Wouterse; Johan Polder; Marc Koopmanschap
Journal:  Eur J Ageing       Date:  2013-05-15

Review 2.  Reducing the costs of chronic kidney disease while delivering quality health care: a call to action.

Authors:  Raymond Vanholder; Lieven Annemans; Edwina Brown; Ron Gansevoort; Judith J Gout-Zwart; Norbert Lameire; Rachael L Morton; Rainer Oberbauer; Maarten J Postma; Marcello Tonelli; Wim Van Biesen; Carmine Zoccali
Journal:  Nat Rev Nephrol       Date:  2017-05-30       Impact factor: 28.314

Review 3.  Pharmacoeconomics and aging.

Authors:  Silvia Bustacchini; Andrea Corsonello; Graziano Onder; Enrico Eugenio Guffanti; Flavio Marchegiani; Angela Marie Abbatecola; Fabrizia Lattanzio
Journal:  Drugs Aging       Date:  2009-12       Impact factor: 3.923

4.  Healthcare Costs Associated with Potentially Inappropriate Medication Prescribing Detected by Computer Algorithm Among Older Patients.

Authors:  Arnaud Pagès; Nadège Costa; Michaël Mounié; Philippe Cestac; Philipe De Souto Barreto; Yves Rolland; Bruno Vellas; Laurent Molinier; Blandine Juillard-Condat
Journal:  Drugs Aging       Date:  2022-05-24       Impact factor: 3.923

Review 5.  The economic burden of inappropriate drug prescribing, lack of adherence and compliance, adverse drug events in older people: a systematic review.

Authors:  Carlos Chiatti; Silvia Bustacchini; Gianluca Furneri; Lorenzo Mantovani; Marco Cristiani; Clementina Misuraca; Fabrizia Lattanzio
Journal:  Drug Saf       Date:  2012-01       Impact factor: 5.606

6.  Proximity to death and participation in the long-term care market.

Authors:  France Weaver; Sally C Stearns; Edward C Norton; William Spector
Journal:  Health Econ       Date:  2009-08       Impact factor: 3.046

7.  Estimating lifetime healthcare costs with morbidity data.

Authors:  Marc Carreras; Pere Ibern; Jordi Coderch; Inma Sánchez; Jose M Inoriza
Journal:  BMC Health Serv Res       Date:  2013-10-25       Impact factor: 2.655

8.  Impact of population ageing on the costs of hospitalisations for cardiovascular disease: a population-based data linkage study.

Authors:  Ninh Thi Ha; Delia Hendrie; Rachael Moorin
Journal:  BMC Health Serv Res       Date:  2014-11-13       Impact factor: 2.655

9.  Hospital Expenditure at the End-of-Life: A Time-to-Death Approach.

Authors:  Vahid Alipour; Abolghasem Pourreza; Majid Kosheshi; Hassan Heydari; Sara Emamgholipour Sefiddashti
Journal:  Int J Health Policy Manag       Date:  2022-02-01

10.  A comparison of HAS & NICE guidelines for the economic evaluation of health technologies in the context of their respective national health care systems and cultural environments.

Authors:  Marc Massetti; Samuel Aballéa; Yann Videau; Cécile Rémuzat; Julie Roïz; Mondher Toumi
Journal:  J Mark Access Health Policy       Date:  2015-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.